Skip to product content

ACTIVE PHARMACEUTICAL INGREDIENT

Amoxicillin API

Research Amoxicillin API through FDA DMF and China CDE records. Compare reported holders, registration numbers and status definitions, then subscribe to search and export complete available data.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

The chemical profile identifies the parent compound, CAS 26787-78-0. Records are selected by reported name; an unspecified hydration state does not establish anhydrous material. Explicit trihydrate, sodium salt and combination entries are excluded.

Amoxicillin registration data overview

This overview includes 15 FDA API DMF records and 26 CDE API registrations for Amoxicillin (CAS 26787-78-0), selected by reported substance name. FDA and CDE status counts follow each registry’s own definitions.

0 documented company-name correspondences

The registries have different snapshot dates. Record counts do not represent qualified or available suppliers. Amoxicillin records without a stated hydration state do not establish anhydrous material. A lack of documented company-name correspondences does not establish that no companies appear in both registries.

Personal API data subscription

$19.00 per month

$149.00 per year

Billed $149.00 every year

This profile: 15 FDA DMF records, 26 CDE registrations and 0 company-name correspondences.

Subscription benefits and CSV samples
  • Complete available registry records
  • Search and status filters
  • Documented company-name correspondences
  • CSV exports with sources

One personal account can access subscription datasets currently available on APIRFQ. Coverage varies by product. This does not include quotations, supplier qualification or live monitoring.

Reported companies in Amoxicillin registry records

Start an Amoxicillin supplier search with the reported names in each market. No cross-registry company-name correspondences are documented for this profile. Similar names, translations and membership of the same corporate group do not prove an identical legal entity or manufacturing site.

Free previewShowing 0 sample records of 0.

0 company-name correspondences

No exact company-name correspondences are documented for these snapshots.

Other records remain available below and in the registry tables. A missing name correspondence does not imply a missing registration.

Original reported names are preserved. A CDE company field may contain several named parties; their roles are not inferred from name order. Unmatched names are not treated as ineligible suppliers.

US REGULATORY RECORDS

Amoxicillin FDA Drug Master Files

Compare the original Amoxicillin subjects, holder names, submission dates and activity status. These name-selected entries leave hydration state unspecified; consult the holder for the actual material form.

15 API DMF records · 13 distinct reported holder names

3Active (A)

12Inactive (I)

A = active; I = inactive. DMFs are neither approved nor disapproved by FDA. These entries do not establish supplier qualification, manufacturing-site approval, dossier access or current availability.

Free previewShowing 3 sample records of 15.

  • TORRENT GUJARAT BIOTECH LTDDMF number 12904Inactive (I)Record details
    DMF number
    12904
    Activity status
    Inactive (I)
    DMF type
    II
    Initial submission
    1998-03-18
    Reported holder
    TORRENT GUJARAT BIOTECH LTD
    Reported subject
    AMOXICILLIN, USP
  • CORDEN PHARMA LATINA SPADMF number 13498Inactive (I)Record details
    DMF number
    13498
    Activity status
    Inactive (I)
    DMF type
    II
    Initial submission
    1998-09-01
    Reported holder
    CORDEN PHARMA LATINA SPA
    Reported subject
    AMOXICILLIN
  • ANTIBIOTICOS SADMF number 13549Active (A)Record details
    DMF number
    13549
    Activity status
    Active (A)
    DMF type
    II
    Initial submission
    1998-09-01
    Reported holder
    ANTIBIOTICOS SA
    Reported subject
    AMOXICILLIN

Free preview

More records available with a subscription: 12.

Inclusion criteria
  • Includes 15 Type II records naming Amoxicillin without an explicit hydrate, sodium salt or finished dosage form. Retains USP, bulk, compacted and enzyme-route descriptions.
  • Excludes related subjects explicitly naming trihydrate, sodium, capsules or oral suspension, including the source spellings AMOXYCILLIN and AMOXCILLIN where they specify trihydrate.
  • Hydration state is not assigned from an unqualified subject. Original holder and subject spelling, whitespace and individual DMF numbers are retained. One holder can have several records.

CHINA REGULATORY RECORDS

Amoxicillin NMPA CDE registrations

Review Amoxicillin registration numbers, reported companies, product origins and joint-review identifiers. The source names include plain and 重粉 entries without specifying hydration state.

26 name-selected API registration records

25Approved for marketed formulations (A)

1Joint review not passed (I)

CDE A and I describe joint-review status, not FDA activity status. In this snapshot, A denotes approval for use in marketed formulations and I denotes material that has not passed joint review with a formulation. Reported validity dates and status do not independently establish current supplier qualification.

Free previewShowing 3 sample records of 26.

  • 哈药集团制药总厂Registration number Y20170001911Joint review not passed (I)Record details
    Registration number
    Y20170001911
    Reported substance name
    阿莫西林
    Reported company names
    哈药集团制药总厂
    Reported company addresses
    哈尔滨市南岗区昆仑商城隆顺街2号(邮寄地址:哈尔滨市香坊区军民街1号)
    Reported product origin
    Domestic (国产)
    Reported packaging
    Not provided by source
    Reported specification
    Not provided by source
    Record updated
    Not provided by source
    Joint review status
    Joint review not passed (I)
    Reported validity date
    Not provided by source
    Source remarks
    CYHB1514131
  • 山东鲁抗医药股份有限公司Registration number Y20170001912Approved for marketed formulations (A)Record details
    Registration number
    Y20170001912
    Reported substance name
    阿莫西林
    Reported company names
    山东鲁抗医药股份有限公司
    Reported company addresses
    山东省邹城市邹城工业园区新华路88号
    Reported product origin
    Domestic (国产)
    Reported packaging
    Not provided by source
    Reported specification
    Not provided by source
    Record updated
    2025-05-14
    Joint review status
    Approved for marketed formulations (A)
    Reported validity date
    2030-08-31
    Source remarks
    CYHB1604364
  • 内蒙古常盛制药有限公司Registration number Y20180000279Approved for marketed formulations (A)Record details
    Registration number
    Y20180000279
    Reported substance name
    阿莫西林
    Reported company names
    内蒙古常盛制药有限公司
    Reported company addresses
    内蒙古自治区呼和浩特市内蒙古托克托工业园区
    Reported product origin
    Domestic (国产)
    Reported packaging
    25kg/桶
    Reported specification
    Not provided by source
    Record updated
    2026-03-21
    Joint review status
    Approved for marketed formulations (A)
    Reported validity date
    2029-09-08
    Source remarks
    Not provided by source

Free preview

More records available with a subscription: 23.

Inclusion criteria
  • Includes the exact reported names 阿莫西林, 阿莫西林(重粉) and 阿莫西林重粉; the powder-grade qualifier is retained without assigning a hydration state.
  • Excludes sodium salts and all reported clavulanate combinations. Original company names, addresses, packaging, specifications, dates and remarks remain unchanged.
  • Semicolon-separated company fields may contain multiple parties. Their roles are not inferred from position. Blank values are displayed as “Not provided by source”.
  • These Amoxicillin records reflect the October 5, 2026 snapshot. A/I is a Chinese review identifier, not FDA activity status; verify current entries on the official platform.

Amoxicillin identity and molecular structure

Amoxicillin is a penicillin compound identified here by CAS 26787-78-0 and ChEBI CHEBI:2676. The formula and structure describe the parent molecule without water of crystallization or a sodium counterion. A registry subject that simply says Amoxicillin does not verify the physical form supplied by a manufacturer.

Amoxicillin — 2D chemical structure

Loading molecular structure…

Open structure in ChEBI
CAS number
26787-78-0
ChEBI: AmoxicillinEDQM: Amoxicillin chemical forms

Parent compound identity; not a CAS assignment verified individually for every registry record.

ChEBI identifier
CHEBI:2676
ChEBI: Amoxicillin
InChIKey
LSQZJLSUYDQPKJ-NJBDSQKTSA-N
ChEBI: Amoxicillin

Amoxicillin chemical properties

Use these parent-compound identifiers to compare chemical references. Amoxicillin trihydrate has a separate CAS number and includes three waters of crystallization. Confirm hydration state, assay basis and the applicable specification with the manufacturer before comparing materials.

Molecular formula
C16H19N3O5S
ChEBI: Amoxicillin
Average molecular mass
365.411 g/mol
ChEBI: Amoxicillin

Average mass reported by ChEBI for the parent compound; not a batch assay or specification.

Monoisotopic mass
365.10454 Da
ChEBI: Amoxicillin

Chemical-form and regulatory resources

Use these official Amoxicillin references to check substance identity and interpret the scope of the registration records.

Amoxicillin API sourcing questions

What chemical identity does this Amoxicillin page cover?

The chemical profile covers Amoxicillin, CAS 26787-78-0, with molecular formula C16H19N3O5S. Its structure represents the parent compound. The registration tables are selected by reported substance names, so they do not confirm that every listed material is anhydrous.

Is Amoxicillin the same as Amoxicillin trihydrate?

Amoxicillin trihydrate contains three waters of crystallization and has CAS 61336-70-7. The parent compound has CAS 26787-78-0. These chemical forms have different formula masses; do not compare assay values or specifications without checking their stated basis. Explicit trihydrate entries are excluded from this profile.

Why are Amoxicillin sodium and clavulanate combinations excluded?

The sodium salt and clavulanate combinations identify different chemical forms or mixtures. They are outside this parent-compound profile. The inclusion rules keep those entries separate from Amoxicillin records rather than treating every matching word as the same material.

Which FDA records are included?

The FDA snapshot contains 15 Type II Amoxicillin records whose subjects do not explicitly name a hydrate, sodium salt or finished dosage form. USP, bulk substance, compacted material and enzyme-route descriptions are retained. Type II alone is insufficient to identify an API because the category also covers other material and drug products.

Does an active Amoxicillin DMF mean the supplier is FDA approved?

No. A and I indicate active and inactive DMFs. FDA states that DMFs are neither approved nor disapproved; technical contents are reviewed with applications that reference them. An Amoxicillin DMF number does not establish manufacturing-site qualification, access to a dossier, current supply or suitability for a particular application.

What do the CDE A and I identifiers mean?

For these Amoxicillin registrations, A and I describe Chinese review status, independently of FDA activity. A identifies material approved for use in marketed formulations; the regulator describes several routes to A status. I identifies material that has not passed technical review or has not been linked to a formulation registration. Check the current official entry when evaluating regulatory support.

Why are 阿莫西林重粉 records included?

The CDE selection includes 阿莫西林, 阿莫西林(重粉) and 阿莫西林重粉. The 重粉 qualifier describes the reported powder grade and is retained exactly. It does not independently identify a sodium salt, combination product or hydration state. Ask the manufacturer for the physical-form specification instead of assigning a different CAS from this qualifier.

How should I compare companies before sourcing Amoxicillin API?

Use the registry number to locate the original entry, then ask the company to confirm its legal name, manufacturing site, chemical form, specification and applicable regulatory documentation. A CDE company field can list multiple parties. This page does not infer their roles from order or equate translated names with an FDA holder.

What data can I preview and export?

Review free Amoxicillin samples and download their sample CSV files before subscribing. An active personal subscription provides the complete available records for this profile, with search, status filters and CSV exports. It does not provide quotations, supplier qualification or live registry monitoring.

ChEBI: AmoxicillinEDQM: Amoxicillin chemical formsFDA DMF list: Q2 2026 snapshotNMPA CDE API registryFDA: Drug Master FilesFDA: Types of Drug Master FilesChina API registration status explained

Data sources

Official references for chemical identity, registration records and status definitions. Open the original source to check current information.

ChEBI: Amoxicillin

Open official source

EMBL-EBI

Parent-compound CAS, molecular formula, calculated masses, InChIKey and stereochemical SMILES.

View citation evidence

“C16H19N3O5S”

EMBL-EBI

Molecular formula reported in the ChEBI entry CHEBI:2676.

EDQM: Amoxicillin chemical forms

Open official source

European Directorate for the Quality of Medicines & HealthCare

The general considerations on page 5 distinguish the anhydrous compound from the trihydrate by CAS and molar mass.

View citation evidence

“amoxicillin trihydrate (CAS: 61336-70-7)”

European Directorate for the Quality of Medicines & HealthCare

Chemical-form identification in the EDSForm Working Party expert opinion; not a manufacturer specification.

FDA DMF list: Q2 2026 snapshot

Open official source

U.S. Food and Drug Administration

The records displayed here use the second-quarter snapshot, with a June 30, 2026 cutoff. The official page may offer a later quarterly list.

View citation evidence

“A=active ; I=inactive”

U.S. Food and Drug Administration

FDA activity-status legend; the snapshot date applies to the records shown here.

FDA: Drug Master Files

Open official source

U.S. Food and Drug Administration

FDA explains how DMFs support applications that reference their technical contents.

View citation evidence

“Are neither approved nor disapproved.”

U.S. Food and Drug Administration

FDA statement about DMFs; active status is not product approval.

FDA: Types of Drug Master Files

Open official source

U.S. Food and Drug Administration

Type II covers drug substances, intermediates, preparation materials and drug products; a subject-level screen is needed to select API records.

View citation evidence

“Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation; or Drug Product”

U.S. Food and Drug Administration

FDA definition of Type II; the category is broader than API-only filings.

NMPA CDE API registry

Open official source

Center for Drug Evaluation, National Medical Products Administration

The October 5, 2026 snapshot contains the reported names, company fields and registration information used here.

View citation evidence

“阿莫西林”

Center for Drug Evaluation, National Medical Products Administration

Original substance name in the CDE snapshot; the name alone does not specify hydration state.

China API registration status explained

Open official source

Liaoning Medical Products Administration

Official explanation of the A and I identifiers, including the different routes by which a record can receive A status.

View citation evidence

“未通过技术审评或尚未与制剂注册进行关联的标识为“I”。”

Liaoning Medical Products Administration

The regulator explains I as material that has not passed technical review or has not been linked to a formulation registration.

Continue your Amoxicillin API research

Compare Amoxicillin registry names, statuses and chemical-form boundaries using the free samples. Subscribe to search, filter and export the complete available FDA and CDE records for your sourcing review.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

Report a data issue

Report an Amoxicillin data issue with the page address, registry number and supporting official source. APIRFQ support handles data corrections; contact the relevant company separately about material specifications or supply.

Contact data support